These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1095 related items for PubMed ID: 17926652

  • 21. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, Haubrich R.
    J Infect Dis; 2006 Jul 01; 194(1):29-37. PubMed ID: 16741879
    [Abstract] [Full Text] [Related]

  • 22. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.
    AIDS; 2008 Aug 20; 22(13):1583-8. PubMed ID: 18670217
    [Abstract] [Full Text] [Related]

  • 23. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
    Zaunders JJ, Cunningham PH, Kelleher AD, Kaufmann GR, Jaramillo AB, Wright R, Smith D, Grey P, Vizzard J, Carr A, Cooper DA.
    J Infect Dis; 1999 Aug 20; 180(2):320-9. PubMed ID: 10395845
    [Abstract] [Full Text] [Related]

  • 24. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
    Qiu ZF, Li TS, Ruan GR, Han Y, Xie J, Zuo LY, Li YL, Wang AX.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun 20; 28(3):386-90. PubMed ID: 16900640
    [Abstract] [Full Text] [Related]

  • 25. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort.
    Glencross DK, Janossy G, Coetzee LM, Lawrie D, Scott LE, Sanne I, McIntyre JA, Stevens W.
    Cytometry B Clin Cytom; 2008 Jun 20; 74 Suppl 1():S131-40. PubMed ID: 18228566
    [Abstract] [Full Text] [Related]

  • 26. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM, López M, Lozano S, González-Lahoz J, Soriano V.
    J Infect Dis; 2008 Nov 15; 198(10):1466-73. PubMed ID: 18847371
    [Abstract] [Full Text] [Related]

  • 27. Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
    García F, Vidal C, Plana M, Cruceta A, Gallart MT, Pumarola T, Miro JM, Gatell JM.
    Clin Infect Dis; 2000 Feb 15; 30(2):392-4. PubMed ID: 10671348
    [Abstract] [Full Text] [Related]

  • 28. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
    Günthard HF, Wong JK, Spina CA, Ignacio C, Kwok S, Christopherson C, Hwang J, Haubrich R, Havlir D, Richman DD.
    J Infect Dis; 2000 Feb 15; 181(2):522-31. PubMed ID: 10669335
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Immunologic features of HIV-1-infected women on HAART at delivery.
    Ono E, Dos Santos AM, Machado DM, Succi RC, Amed AM, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2008 Jul 15; 74(4):236-43. PubMed ID: 18393385
    [Abstract] [Full Text] [Related]

  • 31. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
    Nemes E, Lugli E, Nasi M, Ferraresi R, Pinti M, Bugarini R, Borghi V, Prati F, Esposito R, Cossarizza A, Mussini C.
    AIDS; 2006 Oct 24; 20(16):2021-32. PubMed ID: 17053348
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
    Negredo E, Massanella M, Puig J, Pérez-Alvarez N, Gallego-Escuredo JM, Villarroya J, Villarroya F, Moltó J, Santos JR, Clotet B, Blanco J.
    Clin Infect Dis; 2010 May 01; 50(9):1300-8. PubMed ID: 20367229
    [Abstract] [Full Text] [Related]

  • 34. Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study.
    Llibre JM, Buzón MJ, Massanella M, Esteve A, Dahl V, Puertas MC, Domingo P, Gatell JM, Larrouse M, Gutierrez M, Palmer S, Stevenson M, Blanco J, Martinez-Picado J, Clotet B.
    Antivir Ther; 2012 May 01; 17(2):355-64. PubMed ID: 22290239
    [Abstract] [Full Text] [Related]

  • 35. Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
    Choremi-Papadopoulou H, Tsalimalma K, Dafni U, Dimitracopoulou A, Kordossis T.
    J Med Virol; 2004 Jun 01; 73(2):235-43. PubMed ID: 15122798
    [Abstract] [Full Text] [Related]

  • 36. Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
    Anderson AM, Kosinski AS, Bartlett JA.
    Antivir Ther; 2007 Jun 01; 12(7):1041-8. PubMed ID: 18018762
    [Abstract] [Full Text] [Related]

  • 37. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
    Benveniste O, Flahault A, Rollot F, Elbim C, Estaquier J, Pédron B, Duval X, Dereuddre-Bosquet N, Clayette P, Sterkers G, Simon A, Ameisen JC, Leport C.
    J Infect Dis; 2005 May 15; 191(10):1670-9. PubMed ID: 15838794
    [Abstract] [Full Text] [Related]

  • 38. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE, Zhang W, Diaz RS, Chaloner K, Klinzman D, Stapleton JT.
    HIV Med; 2006 Jan 15; 7(1):25-31. PubMed ID: 16313289
    [Abstract] [Full Text] [Related]

  • 39. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.
    Lécuroux C, Girault I, Boutboul F, Urrutia A, Goujard C, Meyer L, Lambotte O, Chaix ML, Martinez V, Autran B, Sinet M, Venet A, ANRS PRIMO Cohort, ANRS HIC Study Group, ANRS ALT Cohort, ANRS HIC Study Group.
    AIDS; 2009 Aug 24; 23(13):1649-58. PubMed ID: 19617814
    [Abstract] [Full Text] [Related]

  • 40. Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy.
    Wellons MF, Ottinger JS, Weinhold KJ, Gryszowka V, Sanders LL, Edwards LJ, Gooding ME, Thomasch JR, Bartlett JA.
    J Infect Dis; 2001 May 15; 183(10):1522-5. PubMed ID: 11319689
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.